Home
Webinars
About Us
Services
Case Studies
Blogs
Contact Us

Home
Webinars
About Us
Services
Case Studies
Blogs
Contact Us

Join Webinars

Home
Webinars
About Us
Services
Case Studies
Blogs
Contact Us

Join Webinar

Blog

Roche vs. Natco – Genus vs. Species Patent Dispute over Risdiplam

Significant Shift in UPC Pharma Patent Litigation: Sanofi’s Recent Actions

FTC Backs Amneal on Unlawful Orange Book Listings

Novartis vs. Pharmathen: Octreotide

June 11, 2024

Important Update on SPC Regulation Interpretation!

May 7, 2024

Update on Rivaroxaban UK Proceedings: A Roller Coaster Ride for Generic Companies

May 2, 2024

In gratitude and honor of those that enabled me to get to this point.

May 13, 2022

“We are like islands in the sea, separate on the surface but connected in the deep.”― William James

October 22, 2021

“Survival is not the goal, transformative success is.”

August 28, 2021

Making consistent progress towards our goals

August 28, 2021

Sandoz runs into legal dead end for biosimilar Etanercept (Enbrel)

May 19, 2021

Right Advice………

January 4, 2021

Previous Page1 Page2 Next

ipEssentia is a premier Intellectual Property (IP) firm with decades of deep domain expertise in the pharmaceutical and biotech industries. Our singular focus, specialized knowledge, and proven track record make us a trusted partner for companies seeking strategic IP solutions that drive innovation, growth, and competitive advantage.

Important Links

About us
Contact Us
Disclaimer
Privacy Policy
Refund and Cancellation Policy
Shipping Policy
Terms and Conditions

Our Offices:
Delhi NCR (Gurugram, Noida) & Mumbai
INDIA
Call:
Dr. Poonam: +91 8008555339
Dr. Alka: +91 9820797387
info@ipessentia.com

Subscribe to our Newsletter

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Email Address

Designed & Developed by Digicent

Scroll to Top